About us

INAGEN’s core focus
INAGEN has created a novel method of developing new forms of therapies against viral diseases. The technology utilizes a “self targeting capability”, which takes place in the natural defense mechanism of the specific disease, to target and kill infected cells. The platform technology can be utilized to target numerous infectious diseases.

Our Mission is:
to prrovide innovative solutions for the treatment of serious infectious diseases.

Our treatment opportunities must be valuable for patients, societies and our partners

Our Strategy is:

To develop superior innovative biopharmaceuticals with novel mechanisms of action until POC in humans

To utilize strong candidate data to obtain strong partnerships

INAGEN collaborates with world leading academic groups working in the field. This provides INAGEN with an exclusive position regarding novel inventions. At the same time, INAGEN is actively searching for new and stronger elements which can be integrated into future products, thus strengthening IPR. The company will be carrying out all lead development and pre-clinical molecular and cell testing internally, while specific animal testing is out-sourced. All these tests will serve as the foundation for partnering opportunities and clinical testing.